LGG Supplementation in Patients With AUD and ALD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LGG Supplementation in Patients With AUD and ALD — Stella

Recruiting

Back to Alcohol Use Disorder trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Louisville Hospital, Louisville, Kentucky

Key details

Phase

Safety & dosing

Sponsor

University of Louisville

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Enrollment target

~60 participants

Started

June 2022

Primary completion

August 2026

Age range

21 Years – 65 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov